Evercore ISI analyst Liisa Bayko maintained a Buy rating on Enanta Pharmaceuticals (ENTA – Research Report) yesterday and set a price target of ...

CEO John Weinberg highlighted that 2024 was Evercore's second-best year for revenue, reaching over $3 billion in adjusted net revenues, with strength across all business segments. He noted the firm ...

Good morning and welcome to the Evercore fourth quarter 2024 and full year earnings conference call. Today's call is scheduled to last about one hour, including remarks by Evercore management and the ...

Q4 2024 Earnings Call Transcript February 5, 2025 Evercore Inc. beats earnings expectations. Reported EPS is $3.41, ...

Evercore ISI analyst Mark Mahaney maintained a Hold rating on Lyft (LYFT – Research Report) yesterday and set a price target of $19.00. The ...

Evercore ISI downgraded Match Group Inc (NASDAQ:MTCH) to "In Line" from "Outperform," citing a weak first-quarter outlook and uncertainty surrounding its leadership transition, while maintaining its ...

Approached for comment, Atrium CEO John Fowle confirmed that the insurer was working with Evercore and Stone Point to explore ...

Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after ...

Islam Saqib, the Chief Executive Officer of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), sold 48,000 shares of the company's common stock on February 10, 2025. The sale comes as the stock trades near ...

"We're not immune to this [tariffs] — we are less impacted than most of the businesses," PepsiCo chair and CEO Ramon Laguarta ...

Weinberg, Chairman and CEO. "We begin 2025 with strong momentum and we expect the market to continue to gradually improve throughout the year." For the full year 2024, Evercore reported revenue of ...